Vaccine-Antibody-Response-Prediction
--Predicting Post-Vaccination Antibody Levels Using Demographic &amp; Clinical Factors

üìå Project Overview
This project develops and validates a predictive model for log-transformed post-vaccination antibody levels using demographic and clinical variables.
Multiple model families were benchmarked, and a final model was selected based on predictive performance and interpretability, with evaluation on an independent external cohort.

üß† Clinical Question
Can routinely collected demographic and clinical variables be used to predict post-vaccination antibody levels, and does model performance generalize to an independent cohort?

üìä Data
‚Ä¢ dat1: Development cohort: used for training (80%) and internal testing (20%)
‚Ä¢ dat2: Independent cohort: used exclusively for external validation

Outcome
‚Ä¢ Log-transformed antibody level (log_antibody)

Predictors
‚Ä¢ Demographics: age, sex, race/ethnicity
‚Ä¢ Comorbidities: diabetes, hypertension
‚Ä¢ Clinical measures: BMI, systolic blood pressure (SBP), LDL cholesterol
‚Ä¢ Time since vaccination
Note: Data are de-identified and not publicly shared.

üîß Methods

1.Cohort profiling & data quality checks
2.Train/test split with fixed random seed
3.Model benchmarking using 10-fold cross-validation
  ‚Ä¢ Linear regression
  ‚Ä¢ Elastic Net
  ‚Ä¢ Partial Least Squares
  ‚Ä¢ Generalized Additive Model (GAM)
  ‚Ä¢ MARS
4.Model selection based on RMSE and interpretability
5.Internal testing (dat1 hold-out)
6.External validation (dat2)
Primary metric: RMSE
Secondary metrics: MAE, R¬≤

üìà Key Results
Model Performance Comparison
![Models Comparison](figures/model_comparison.png)
Final model was selected based on smallest RMSE, so GAM model performed better than others. 

Calibration Plots

Internal Test (dat1)
![Internal Test](figures/pred_vs_obs_internal.png)

External Validation (dat2)
![External Test](figures/pred_vs_obs_external.png)

‚Ä¢ Internal predictions closely align with the identity line
‚Ä¢ External predictions show increased uncertainty with mild underestimation at higher antibody levels
‚Ä¢ Overall linear association is preserved, indicating reasonable transportability

Model Interpretability

The final GAM model captures non-linear relationships between antibody levels and key predictors such as:
‚Ä¢ Age
‚Ä¢ BMI
‚Ä¢ Time since vaccination
![GAM smooth terms](figures/gam_smooth_terms.png)

‚ö†Ô∏è Limitations

‚Ä¢ Observational design (no causal interpretation)
‚Ä¢ Potential cohort shift between development and validation cohorts
‚Ä¢ Extreme antibody values show higher prediction uncertainty